
Annals of the Rheumatic Diseases (ARD)
is a leading rheumatology journal from BMJ and EULAR, publishing original research, reviews and recommendations
Impact Factor: 19.103
Citescore: 28.5
All metrics >>Â
Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.
ARD is an official journal of EULAR.
Free lay summaries are provided for selected research articles and all EULAR recommendations. You can keep up with the latest news via Twitter and Facebook.
Listen to the ARD podcast and subscribe in all podcast platforms, including Apple Podcast, Google Podcasts, Stitcher and Spotify.
Editor-in-Chief: Professor Josef Smolen, Medical University of Vienna, Austria
Editorial team
ARD is a Plan S compliant Transformative Journal.